Upload Avatar (500 x 500)
Lei Cao
leicao@njmu.edu.cn
Chinese, English
Jiangsu
Nanjing Medical University
Basic Medical Sciences
  • 2007-09 to 2012-07 Bachelor's in Clinical Medicine: Nanjing Medical University
  • 2012-09 to 2015-07 Master's in Pharmacology: Nanjing Medical University
  • 2018-08 to 2021-05 PhD in Pharmacology: National University of Singapore
  • 2016-08 to 2018-07 - National University of Singapore - Assistant Researcher
  • 2022-01 to Present - Nanjing Medical University - Associate Professor, Master's Supervisor
Pathological mechanisms of Parkinson's disease and drug target discovery
  • Anti-Na(+)/K(+)-ATPase immunotherapy ameliorates alpha-synuclein pathology through activation of Na(+)/K(+)-ATPase alpha1-dependent autophagy., Cao, L., Xiong, S., Wu, Z., Ding, L., Zhou, Y., Sun, H., Zhu, M., Lee, W. T., Nie, X., & Bian, J. S., 2021
  • Hydrogen sulfide inhibits ATP-induced neuroinflammation and Abeta(1-42) synthesis by suppressing the activation of STAT3 and cathepsin S., Cao, L., Cao, X., Zhou, Y., Nagpure, B. V., Wu, Z. Y., Hu, L. F., Yang, Y., Sethi, G., Moore, P. K., & Bian, J. S., 2018
  • Therapeutic potential of sulfur-containing natural products in inflammatory diseases., Cao, X., Cao, L., Zhang, W., Lu, R., Bian, J. S., & Nie, X., 2020
  • DR-region of Na(+)/K(+) ATPase is a target to treat excitotoxicity and stroke., Shi, M., Cao, L., Cao, X., Zhu, M., Zhang, X., Wu, Z., Xiong, S., Xie, Z., Yang, Y., Chen, J., Wong, P. T. H., & Bian, J. S., 2018
  • Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson's Disease., Liu, Y., Cao, L., Song, Y., Kang, Z., Liu, T., Ding, J., Hu, G., & Lu, M., 2022
Parkinson'S Disease Pathological Mechanisms Drug Targets Neurodegenerative Diseases Neuroinflammation Autophagy Alpha-Synuclein Na(+)/K(+)-Atpase Immunotherapy Pharmacology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.